Top compounds associated with response to RP11-529K1.3


Feature Type Standardized
Nominal ANOVA
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA BRD1835 CTRPv2 pan-cancer AAC 0.087 0.02
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.02
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.084 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA YM-155 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA semagacestat CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV